Humanitarian NGOs rely on generics

By 2010, such purchases were predominantly generic drugs [56]. For example, by 2008, 95% (by volume) of the global donor-funded ARV market was comprised of generics, primarily from India[57]. The generic proportion of PEPFAR-purchased ARVs grew from 15% to 89% from 2005 to 2008, with estimated savings to PEPFAR totalling $323 million over the four-year period [58].

Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
Ellen ‘t Hoen, Jonathan Berger, Alexandra Calmy, and Suerie Moon




Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s